Piramal Enterprises’ PPS to expand its API manufacturing facilities

11 Oct 2017 Evaluate

Piramal Pharma Solutions (PPS), part of Piramal Enterprises (PEL) will be making an investment of $55 million across its sites in North America and Asia in order to expand its API manufacturing capabilities and capacities.

Out of $55 million, a part of investment will go into new multi-purpose plants, with over 270kL of total capacity, to support the current pipeline of around 80 late stage programs that PPS is currently assisting its partners with at various global sites.

Piramal Enterprises (PEL) is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 950.50
Shriram Finance 995.55
Aditya Birla Capital 361.70
Chola Invest & Fin. 1699.45
Tata Capital 358.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×